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Osteoporosis is a disease associated with an increased
risk of fractures. Vertebral and hip fractures are asso-
ciated with high mortality or loss of autonomy. The aim
of this review is to explore the scientific evidence for
current therapies for postmenopausal osteoporosis and
fractures and to establish how to treat osteoporosis in
clinical practice without risk for patients.
We performed research by the use of pubmed of all
randomized controlled trials on osteoporosis therapy.
The key works used were “osteoporosis therapy”; “post-
menopausal osteoporosis” and “osteoporosis trial”.
Efficacious pharmacological therapy include alendro-
nate, risedronate, hormone replacement therapy, stron-
tium ranelate, that are successful agents for femoral and
vertebral sites. All osteoporosis patients may take cal-
cium and vitamin D supplementation often not recom-
mended by the physicians. Treatment of Osteopenic
patients need further evidence. Early diagnosis and treat-
ment can help to reduce the complications such as frac-
tures but adverse effects may be monitoring and need
particular knowledge in this setting [1-4].
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